Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS one, volume 14, issue 11, e0224751 (2019), doi:10.1371/journal.pone.0224751
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2019
- Creator
-
Mücke, Marcus Maximilian
Maasoumy, Benjamin
Dietz, Julia
Mücke, Victoria Therese
Simon, Christian O.
Canchola, Jesse
Cornberg, Marcus
Marins, Ed G.
Manns, Michael P.
Zeuzem, Stefan
Wedemeyer, Heiner
Sarrazin, Christoph
Vermehren, Johannes
- URN
-
urn:nbn:de:hebis:30:3-516983
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mücke, Marcus Maximilian
- Maasoumy, Benjamin
- Dietz, Julia
- Mücke, Victoria Therese
- Simon, Christian O.
- Canchola, Jesse
- Cornberg, Marcus
- Marins, Ed G.
- Manns, Michael P.
- Zeuzem, Stefan
- Wedemeyer, Heiner
- Sarrazin, Christoph
- Vermehren, Johannes
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2019
Other Objects (12)
Current and future treatment options for HCV
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Reply to "Vitamin D deficiency and HCV chronic infection: What comes first?"
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Hauptthema Interdisziplinäres Management bei fortgeschrittener Leberzirrhose : eingeladene Beiträge, interdisziplinäres Gespräch
Current and future treatment options for HCV
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Reply to "Vitamin D deficiency and HCV chronic infection: What comes first?"
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
IL28B single nucleotide polymorphisms in the treatment of hepatitis C
Hauptthema Interdisziplinäres Management bei fortgeschrittener Leberzirrhose : eingeladene Beiträge, interdisziplinäres Gespräch
Current and future treatment options for HCV
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
Forewarned is forearmed
Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten
Chronische Virushepatitiden : Biologie, Diagnostik und Therapie
Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen
Reply to: ‘Evidence recommending antiviral therapy in hepatitis C’
Reply to "Vitamin D deficiency and HCV chronic infection: What comes first?"
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Overcoming the roadblocks in hepatitis C virus infection
IL28B single nucleotide polymorphisms in the treatment of hepatitis C